Expression of the matrix metalloproteinase promatrilysin in coculture of prostate carcinoma cell lines

Prostate

Volumn 48, Issue 3, 2001, Pages 206-209

  Stratton, M S ^a   Sirvent, H ^a   Udayakumar, T S ^a   Nagle, R B ^a   Bowden, G T ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Coculture; DU 145; IL 6; LNCaP; Matrilysin; Prostate carcinoma

Indexed keywords

ENZYME PRECURSOR; INTERLEUKIN 6; MATRILYSIN; MATRIX METALLOPROTEINASE; NEUTRALIZING ANTIBODY; PROMATRILYSIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

CARCINOMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 7; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0034899148     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.1099     Document Type: Article

References (18)

1. Matrix metalloproteinase family
2. Metalloproteinase domain structure, cellular invasion and metastasis
3. Metalloproteinase expression and hormonal regulation during tissue remodeling in the cycling human endometrium
4. Matrix metalloproteinases in tumour invasion and metastasis
5. Matrix metalloproteinases and oral cancer
6. Matrilysin expression in the involuting rat ventral prostate
7. Localization and expression of matrix metalloproteinase-7 in human prostate
8. Matrilysin expression in human prostate carcinoma
9. Prostate tumor cell invasion: A comparison of orthotopic and ectopic models
10. Interleukin-1beta secreted from monocytic cells induces the expression of matrilysin in the prostatic cell line LNCaP
11. Characterization of the role of IL-6 in the progression of prostate cancer
12. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro
13. Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer
14. Serum interleukin 6 as a prognostic factor in patients with prostate cancer
15. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor
16. Antiproliferative effect of a prostatic cell-derived activity on the human androgen-dependent prostatic carcinoma cell line LNCaP
17. STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells
18. STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP